-

Owens & Minor Launches ByramConnect Digital Health Platform for Diabetes and Other Chronic Health Conditions

Now available as a free service exclusively to Byram Healthcare customers, ByramConnect powered by the Welldoc App combines digital health coaching, self-tracking, clinically relevant insights and education to support members with diabetes and associated chronic health conditions throughout their health journey.

RICHMOND, Va.--(BUSINESS WIRE)--Byram Healthcare, a leader in home-based care and part of the Owens & Minor (NYSE: OMI) family, recently launched ByramConnectTM, a personalized digital health program powered by the Welldoc App®. Using the Welldoc App’s advanced artificial intelligence capabilities, the program analyzes member data across six dimensions of health to help optimize outcomes for people with type 1 or type 2 diabetes and associated chronic conditions such as hypertension, weight management, and cardiovascular risk, providing Byram members with actionable insights and reports that can be shared with their providers and care teams.

“Chronic health conditions like diabetes are complex and can have long-term health implications that require multiple supportive interventions over the course of a member’s care journey,” said Perry Bernocchi, EVP and CEO, Patient Direct, Owens & Minor. “We’re proud to offer Byram members a clinically validated platform designed to help them achieve concrete goals, such as weight management and improved control over their diabetes, in addition to longer-lasting behavior changes that help support a lifetime of better overall health.”

ByramConnect powered by the Welldoc App is a U.S. Food and Drug Administration (FDA)-cleared class II software as a medical device (SaMD) intended for use by healthcare providers and adult patients with type 1 or type 2 diabetes*. In clinical studies, patients using the app saw improvements in several important measures related to their condition, including reduced (A1C), lower blood pressure and lower body weight.1-4 The ByramConnect platform offers Byram diabetes customers access to the Welldoc App, which provides their care teams a holistic view of their condition by combining patient-tracked health data and connected sources such as fitness trackers, blood glucose meters, continuous glucose monitors (CGMs), blood pressure monitors, scales, heart rate monitors and medical labs and pharmacies.

Additional ByramConnect powered by the Welldoc App benefits include:

  • Digital coaching: personalized, AI-driven digital coaching providing real-time feedback and coaching based on a patient’s unique data and trends
  • Diet and nutrition support: tracking, insights and guidance to help promote healthy eating habits, including meal planning and restaurant recommendations based on dietary requirements
  • GLP-1 medication support: support to help patients manage medications, monitor potential side-effects and track adherence over time
  • Reporting & insights: health reports with actionable insights based on the patient’s unique data, patterns and trends that patients can share with their provider and care team
  • Mental wellbeing: guidance and reinforcement to help members manage overall wellbeing, including mood, sleep and anxiety

*Welldoc Diabetes and Welldoc Diabetes Rx is an FDA-cleared medical device, intended for use by healthcare providers and their adult patients with type 1 or type 2 diabetes. For full labeling information, visit www.welldoc.com. The other Welldoc App products are non-FDA-cleared and intended to promote general wellness and education/self-management of various chronic disease states.

ByramConnect powered by the Welldoc App can be used on any device and is available now as an included service exclusively for Byram diabetes customers at no additional charge. Byram customers will receive an invitation via email within the next couple of weeks with an exclusive access code allowing them to download the app from the Apple or Google Play App stores. More information about ByramConnect powered by the Welldoc App can be found at byramhealthcare.com/byram-connect-powered-by-welldoc.

About Owens & Minor

Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home. For over 100 years, Owens & Minor and its affiliated brands, Apria®, Byram® and HALYARD*, have helped to make each day better for the patients, providers and communities we serve. Powered by more than 20,000 teammates worldwide, Owens & Minor delivers comfort and confidence behind the scenes so healthcare stays at the forefront. Owens & Minor exists because every day, everywhere, Life Takes Care™.

For more information about Owens & Minor and our affiliated brands, visit owens-minor.com or follow us on LinkedIn and Instagram.

*Registered Trademark or Trademark of O&M Halyard or its affiliates.

About Byram

Byram Healthcare (“Byram” or “Byram Healthcare Centers, Inc.”), part of the Owens & Minor family, delivers the products, services and support patients need to help improve health outcomes and affordability of care in the home. Along with Apria, Byram Healthcare makes up the Owens & Minor Patient Direct business segment, which serves nearly three million patients each year and offers one of the broadest portfolios of products for chronic and acute conditions including diabetes, wound care, sleep health, respiratory care, urology and ostomy care. For more information, visit byramhealthcare.com.

About Welldoc®

Welldoc, a digital health leader revolutionizing cardiometabolic care, is integrating personalized, real-time and actionable insights into the daily lives of individuals living with cardiometabolic conditions, enabling improved health and outcomes. Welldoc’s comprehensive digital health platform provides AI-powered digital coaching across pre-diabetes, diabetes, hypertension, heart failure and weight and obesity management, with integrated mental wellbeing and sleep support. The Welldoc App is an FDA-cleared digital health solution that guides individuals through the complicated journey of living with diabetes by enabling them to self-manage their care while enhancing connections to their healthcare team. For more information, visit www.welldoc.com.

______________

1. Quinn, et al. Diabetes Care (2011).

2. Kumbara et al. Diabetes Technology (2022).

3. Welldoc Data on File.

4. CDC. Workplace Health Promotion (2022).

OMI-CORP
OMI-IR

Contacts

Media
Stacy Law, Owens & Minor
media@owens-minor.com

Owens & Minor

NYSE:ACH
Details
Headquarters: Richmond, VA
CEO: Edward Pesicka
Employees: 6000
Organization: PUB

Release Summary
Available exclusively to Byram Healthcare customers, ByramConnect powered by the Welldoc App combines coaching, self-tracking, insights & education.
Release Versions

Contacts

Media
Stacy Law, Owens & Minor
media@owens-minor.com

Social Media Profiles
More News From Owens & Minor

Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that on October 6, 2026, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) notifying the Company that it is not in compliance with the NYSE’s continued listing standards because the average closing price of the Company’s Class A Common Stock (the “Common Stock”) was less than $1.00 per share over a consecutive 30 trading-day period. The Notice does not result in the im...

Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today named Kenneth Gardner-Smith as the Company’s next President and Chief Executive Officer. Gardner-Smith, who has served on the Company’s Board of Directors since March 2022, is expected to assume the role early in the fourth quarter 2026. He will succeed Edward A. Pesicka, who announced his intent to retire in August. Gardner-Smith brings deep experience running large-scale patient care operations and guiding...

Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health (the “Company”) is providing an update on its capital allocation plans and the timeline for the replacement of its chief executive officer. Given recent market conditions, the Company has determined that it is in the best interest of stakeholders not to put in place an at-the-market issuance program. The program was intended to allow the Company to opportunistically issue modest amounts of equity over time, with the proceeds to be used to reduce o...
Back to Newsroom